Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study.

Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study. Breast Cancer Res. 2014 May 26; 16(3):R51.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.